Implications of the development of biosimilars for cancer treatment.
Mellstedt
Håkan
H
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001702:Biopharmaceutics / Q000191:economics / Q000639:trends; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010330:Patents as Topic; D013810:Therapeutic Equivalency
D000970:Antineoplastic Agents